INN: Heparin sodium
Presentation: solution for intravenous and subcutaneous administration 5000 ME/ml 5 ml vial 5 units per pack
Included in the List of Vital and Essential Drugs
Registration number: R N002077/01
By prescription
Pharmacotherapeutic group: direct-action anticoagulant.
Indications for use:
- thrombosis, thromboembolism (prevention and treatment);
- prevention of blood clotting (in cardiovascular surgery);
- coronary thrombosis;
- disseminated intravascular coagulation;
- post-operative period in patients with a history of thromboembolic diseases;
- binhibition of blood clotting during extracorporeal circulation.
Shelf life: 4 years